Valeant, Pershing go hostile in $53.8 billion Allergan bid
June 02, 2014 at 09:59 AM EDT
(Reuters) - Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker's shareholders, and ally Pershing Square called for a meeting to turn over the target company's board.